Potent aminocyclitol glucocerebrosidase inhibitors are subnanomolar pharmacological chaperones for treating gaucher disease.

Potent aminocyclitol glucocerebrosidase inhibitors are subnanomolar pharmacological chaperones for treating gaucher disease.

Amino-myo-inositol derivatives have been found to be potent inhibitors of glucocerebrosidase (GCase), the β-glucosidase enzyme deficient in Gaucher disease (GD). When tested using lymphoblasts derived from patients with GD homozygous for N370S or L444P mutations, the compounds enhanced GCase activit...

書誌詳細
主要な著者:	Trapero, A, González-Bulnes, P, Butters, T, Llebaria, A
フォーマット:	Journal article
言語:	English
出版事項:	2012

類似資料

Polyhydroxylated bicyclic isoureas and guanidines are potent glucocerebrosidase inhibitors and nanomolar enzyme activity enhancers in Gaucher cells.
著者:: Trapero, A, 等
出版事項: (2011)

Chaperoning glucocerebrosidase: a therapeutic strategy for both Gaucher disease and Parkinsonism
著者:: Benjamin McMahon, 等
出版事項: (2016-01-01)

Rational design and synthesis of highly potent pharmacological chaperones for treatment of N370S mutant Gaucher disease.
著者:: Wang, G, 等
出版事項: (2009)

Synthesis of N-substituted ε-hexonolactams as pharmacological chaperones for the treatment of N370S mutant Gaucher disease.
著者:: Wang, G, 等
出版事項: (2012)

Progranulin Recruits HSP70 to β-Glucocerebrosidase and Is Therapeutic Against Gaucher Disease
著者:: Jinlong Jian, 等
出版事項: (2016-11-01)

Effect of macrophage-targeted glucocerebrosidase(alglucerase) on hypolipidaemia of type 1 Gaucher disease(GD)
著者:: Mistry, P, 等
出版事項: (1997)

Docking study and biological evaluation of pyrrolidine-based iminosugars as pharmacological chaperones for Gaucher disease
著者:: Kato, A, 等
出版事項: (2016)

Abstract P-43: Effect of Glucocerebrosidase Dysfunction on the Pool of Plasma Exosomes of Patients with Gaucher Disease
著者:: Luiza A. Garaeva, 等
出版事項: (2021-06-01)

N- and C-alkylation of seven-membered iminosugars generates potent glucocerebrosidase inhibitors and F508del-CFTR correctors.
著者:: Désiré, J, 等
出版事項: (2014)

Engineering synthetic and recombinant human lysosomal β-glucocerebrosidase for enzyme replacement therapy for Gaucher disease
著者:: Figueiredo, Lílian L. S., 等
出版事項: (2024)

Engineering synthetic and recombinant human lysosomal β-glucocerebrosidase for enzyme replacement therapy for Gaucher disease
著者:: Lílian L. Souza Figueiredo, 等
出版事項: (2024-10-01)

Gaucher disease.
著者:: Butters, T
出版事項: (2007)

Concise and enantioselective synthesis of the aminocyclitol core of hygromycin A.
著者:: Donohoe, T, 等
出版事項: (2005)

Recent progress in the synthesis of six-membered aminocyclitols (2008-2017)
著者:: William A. Donaldson
出版事項: (2018-05-01)

Therapeutic delivery of recombinant glucocerebrosidase enzyme-containing extracellular vesicles to human cells from Gaucher disease patients
著者:: Keatdamrong Janpipatkul, 等
出版事項: (2024-10-01)

High throughput screening for small molecule therapy for Gaucher disease using patient tissue as the source of mutant glucocerebrosidase.
著者:: Ehud Goldin, 等
出版事項: (2012-01-01)

in silico identification of genetic variants in glucocerebrosidase (GBA) gene involved in Gaucher’s disease using multiple software tools.
著者:: Madhumathi eManickam, 等
出版事項: (2014-05-01)

Amphiphilic 1-deoxynojirimycin derivatives through click strategies for chemical chaperoning in N370S Gaucher cells.
著者:: Diot, J, 等
出版事項: (2011)

A new glucocerebrosidase-deficient neuronal cell model provides a tool to probe pathophysiology and therapeutics for Gaucher disease
著者:: Wendy Westbroek, 等
出版事項: (2016-07-01)

A myo-inositol dehydrogenase involved in aminocyclitol biosynthesis of hygromycin A
著者:: Michael O. Akintubosun, 等
出版事項: (2024-03-01)

Second-Generation Pharmacological Chaperones: Beyond Inhibitors
著者:: My Lan Tran, 等
出版事項: (2020-07-01)

Hydrophobic Rose Bengal Derivatives Exhibit Submicromolar-to-Subnanomolar Activity against Enveloped Viruses
著者:: Anna A. Rubekina, 等
出版事項: (2022-11-01)

Activation and Purification of ß‐Glucocerebrosidase by Exploiting its Transporter LIMP‐2 – Implications for Novel Treatment Strategies in Gaucher's and Parkinson's Disease
著者:: Jan Philipp Dobert, 等
出版事項: (2024-07-01)

A NOVEL SYNTHETIC AND RECOMBINANT GLUCOCEREBROSIDASE FOR GAUCHER DISEASE: IN SILICO MOLECULAR EVOLUTION AND GENE THERAPY APPROACHES TO ENHANCE ENZYME ACTIVITY
著者:: LLS Figueiredo, 等
出版事項: (2023-10-01)

INVESTIGATIONS ON THE RESISTANCE OF COMMENSAL SWINE ESCHERICHIA COLI TO SOME AMINOGLYCOSIDES-AMINOCYCLITOLS
著者:: Valentina Urumova, 等
出版事項: (2016-03-01)

Design of a New α-1-C-Alkyl-DAB Derivative Acting as a Pharmacological Chaperone for β-Glucocerebrosidase Using Ligand Docking and Molecular Dynamics Simulation
著者:: Izumi Nakagome, 等
出版事項: (2018-10-01)

Different and unusual presentation of Gaucher’s disease with the same mutation in the glucocerebrosidase enzyme (F266L) in two patients: a case report
著者:: Bijan Keikhaei, 等
出版事項: (2024-11-01)

Crystal structures of complexes of N-butyl- and N-nonyl-deoxynojirimycin bound to acid beta-glucosidase: insights into the mechanism of chemical chaperone action in Gaucher disease.
著者:: Brumshtein, B, 等
出版事項: (2007)

Regioselectivity in the Ring Opening of Epoxides for the Synthesis of Aminocyclitols from D-(-)-Quinic Acid
著者:: Shu-Yu Yang, 等
出版事項: (2012-04-01)

Synthesis of a new class of aminocyclitol analogues with the conduramine D-2 configuration
著者:: Latif Kelebekli, 等
出版事項: (2010-02-01)

Lysosomal lipid alterations caused by glucocerebrosidase deficiency promote lysosomal dysfunction, chaperone-mediated-autophagy deficiency, and alpha-synuclein pathology
著者:: Alba Navarro-Romero, 等
出版事項: (2022-10-01)

Quantification in the subnanomolar range of phospholipids and neutral lipids by monodimensional thin-layer chromatography and image analysis
著者:: J I Ruiz, 等
出版事項: (1997-07-01)

Small Molecule Chaperones for the Treatment of Gaucher Disease and GBA1-Associated Parkinson Disease
著者:: Tae-Un Han, 等
出版事項: (2020-05-01)

Cellular and biochemical response to chaperone versus substrate reduction therapies in neuropathic Gaucher disease
著者:: Margarita M. Ivanova, 等
出版事項: (2021-01-01)

Parkinsonisms and Glucocerebrosidase Deficiency: A Comprehensive Review for Molecular and Cellular Mechanism of Glucocerebrosidase Deficiency
著者:: Emilia M. Gatto, 等
出版事項: (2019-02-01)

Unveiling the Role of Cholesterol in Subnanomolar Ouabain Rescue of Cortical Neurons from Calcium Overload Caused by Excitotoxic Insults
著者:: Dmitry A. Sibarov, 等
出版事項: (2023-08-01)

Structural determinants for subnanomolar inhibition of the secreted aspartic protease Sapp1p from Candida parapsilosis
著者:: Jiří Dostál, 等
出版事項: (2021-01-01)

Comparative Study of Erythrocyte Sedimentation Rate after Aminoglycoside and Aminocyclitol Treatment in Goats (Capra hircus)
著者:: Toncho DINEV, 等
出版事項: (2016-07-01)

Imino sugar therapy for type 1 Gaucher disease.
著者:: Priestman, D, 等
出版事項: (2000)

N,Zn-Doped Fluorescent Sensor Based on Carbon Dots for the Subnanomolar Detection of Soluble Cr(VI) Ions
著者:: Enoch Kwasi Adotey, 等
出版事項: (2023-02-01)